Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Genprex, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 17 | 15 | −2 |
| Shares | 143.1K | 270.8K | +127.7K (+89.3%) |
| Value | $426.0K | $510.3K | +$84.3K (+19.8%) |
New holders (2)
Institutions that held Genprex, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Brown Brothers Harriman & Co | 2,500 | $4.71K | 0.00% |
| Global Retirement Partners, LLC | 5 | $9 | 0.00% |
Sold out (4)
Institutions that held Genprex, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Sofos Investments, Inc. | 21 | $62 |
| Wells Fargo & Company | 11 | $33 |
| Signaturefd, LLC | 1 | $3 |
| Advisor Group Holdings, Inc. | 1 | $2 |